A new generation of compounds for the treatment for diabetes type 2

  1. Du är här:
  2. Start
  3. Naturvetenskapliga fakulteten
  4. Samverkan
  5. Våra samarbeten
  6. A new generation of compounds for the treatment for diabetes type 2

Short facts:

  • Bengtssons’s research group at Stockholm University is investigating how novel adrenergic signaling stimulates glucose uptake in tissues
  • Atrogi AB, a company that develops drugs against metabolic disorders such as type 2 diabetes